Universität des Saarlandes

ACTIVE

Campus Gebäude B 21, Saarbrücken, Saarland, Germanywww.uni-saarland.dePrivate1,001–5,000 employeesEstablished: 1948-01-01

Also known as:

institut für alte geschichte - altertumswissenschaften

institut für handel und internationales marketing

universitätsklinikum des saarlandes nephrologisch immunologisches labor

lehrstuhl für intelligente materialsysteme

europa-institut der universität des saarlandes

zentrum für informations- und kommunikationstechnik (zik)

universitätsklinikum des saarlandes/ personalkasino

pharmazeutische biotechnologie

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1948

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

32.8%

Phase 2

9.0%

Phase 3

7.5%

Phase 4

3.0%

Early Phase 1

1.5%

Phase 1

1.5%

Trial Status Distribution

Active, not recruiting

1.5%

Completed

64.2%

Not yet recruiting

7.5%

Recruiting

19.4%

Terminated

1.5%

Unknown

6.0%

Clinical Trials

Trials sponsored by this organization (67)

Combating Multidrug-resistant Gram-negative Bacteria in Africa Through Diagnostic and Antimicrobial Stewardship

Not Applicable

Not yet recruiting

interventional

Nov 20271,320 participants

DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients

Not yet recruiting

observational

Sep 202630 participants

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents

Not yet recruiting

observational

Sep 20264,907 participants

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

Phase 3

Recruiting

interventional

Oct 2025214 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

Back to Organizations

Universität des Saarlandes

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (67)

Combating Multidrug-resistant Gram-negative Bacteria in Africa Through Diagnostic and Antimicrobial Stewardship

DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

Time-restricted Feeding in MASLD

Sex diffErences in prehoSpitAl Stroke MEdicine

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis

Approvals

News